FDA Approved: TORISEL — Original Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

View source ↗

Summary

FDA approved temsirolimus (Torisel) in an original application for the treatment of advanced renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Torisel (Temsirolimus)

Snippet

ORIG AP for TORISEL (TEMSIROLIMUS)